GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Minority Interest

Nuformix (LSE:NFX) Minority Interest : £0.00 Mil (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Nuformix's minority interest for the quarter that ended in Sep. 2022 was £0.00 Mil.


Nuformix Minority Interest Historical Data

The historical data trend for Nuformix's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Minority Interest Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Minority Interest
Get a 7-Day Free Trial - - - - -

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nuformix Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.


Nuformix (LSE:NFX) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Nuformix (LSE:NFX) Headlines

From GuruFocus

5 Oil & Gas Companies To Consider This Year

By InvestmentUnderground InvestmentUnderground 03-25-2012

Newfield Exploration Releases Second Quarter Report

By Black Iguana Nitish 09-30-2014

Newfield Exploration Company (NFX) EVP and COO Gary D Packer sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 12-13-2010